Mostrar 1 - 5 resultats de 5 per cerca 'Seyed Reza Mousavi (13223324)', hora de la petició: 0.01sec Refinar resultats
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. per Seyed Reza Mousavi (13223324)

    Publicat 2025
    Afegir a favorits
    Guardat en:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. per Seyed Reza Mousavi (13223324)

    Publicat 2025
    Afegir a favorits
    Guardat en:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. per Seyed Reza Mousavi (13223324)

    Publicat 2025
    Afegir a favorits
    Guardat en:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. per Seyed Reza Mousavi (13223324)

    Publicat 2025
    Afegir a favorits
    Guardat en:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. per Seyed Reza Mousavi (13223324)

    Publicat 2025
    Afegir a favorits
    Guardat en:

Eines de cerca: